− dendritic cells (DCs) are pathogenic for colitis. Unveiling molecular mechanisms that render these cells proinflammatory is important for the design of specific immunotherapies. In this report, we demonstrated that mesenteric lymph node CD103 − DCs express, among other proinflammatory cytokines, high levels of osteopontin (Opn) during experimental colitis. Opn expression by CD103
I
nflammatory bowel diseases (IBDs), including Crohn disease (CD) and ulcerative colitis (UC), are caused by excessive inflammatory responses to commensal microflora and other antigens present in the intestinal lumen (1) . Intestinal dendritic cells (DCs) contribute to these inflammatory responses during human IBD, as well as in murine colitis models (2) . DCs that reside in draining mesenteric lymph nodes (MLNs) are also crucial mediators of colitis induction (3) and may be grouped based on their surface CD103 (integrin αE) expression as CD11c high CD103 + (CD103 + DCs) and CD11c high CD103 − (CD103 − DCs) (4-6). CD103 + DCs are considered important mediators of gut homeostasis in steady state (4, 5, (7) (8) (9) , and their tolerogenic properties are conserved between mice and humans (5) . However, their role during intestinal inflammation is not well defined. Instead, CD103
− DC function has been described mostly during chronic experimental colitis (10) (11) (12) . These cells secrete IL-23, IL-6, and IL-12 (10) (11) (12) , contributing to the development of T helper (Th) 17 and Th1 cells, and are highly inflammatory during CD4 + T-cell transfer colitis (12) and during 2,4,6 trinitrobenzene sulfonic acid (TNBS)-induced chronic colitis (11) . MLN CD103 − DCs cultured in the presence of LPS, a Toll-like receptor (TLR) 4 agonist, or R848, a TLR7 agonist, express higher levels of TNF-α and IL-6 (7, 12) . In fact, these cells secrete IL-23 and IL-12 even in the absence of TLR stimulation (10) . Both MLN CD103
− and CD103 + DC subsets are present in acute colitis (11, 13) ; however, their function, as well as their cytokine profile, during this phase of disease, reflecting colitis initiation, remains unknown.
Recent studies suggest a proinflammatory role for the cytokine osteopontin (Opn) in TNBS-and dextran sulfate sodium (DSS)-induced colitis (14, 15) , which are the models for CD and UC, respectively. Opn is expressed by DCs and other immune cell types, such as lymphocytes, during autoimmune responses (16) (17) (18) (19) (20) (21) (22) , and its expression by DCs during autoimmunity contributes to disease severity (17-19, 21, 23) . In addition, Opn expression is highly up-regulated in intestinal immune and nonimmune cells and in the plasma of patients with CD and UC (24) (25) (26) (27) (28) (29) , as well as in the colon and plasma of mice with experimental colitis (14, 15, 27, 30) . Increased plasma Opn levels are related to the severity of CD inflammation (29) , and certain Opn gene (Spp1) haplotypes are modifiers of CD susceptibility (31) , indicating that Opn could be used as an IBD biomarker (27) . In general, Opn affects DC biology during several inflammatory conditions (17) (18) (19) (20) (21) (32) (33) (34) (35) (36) (37) and could be a potential therapeutic target in IBD.
In this study, we initially asked whether Opn was expressed by MLN CD103
− and CD103 + DCs during colitis. We found that CD103
− DCs express excessive levels of Opn in addition to other proinflammatory cytokines. Conversely, CD103
+ DCs express profoundly lower levels of Opn and are noninflammatory. Using adoptive transfer of purified specific DC subsets, we determined that MLN CD103
− DCs are critical mediators of acute intestinal inflammation and that their Opn expression is essential for their proinflammatory properties in both acute and chronic colitis. Furthermore, Opn-deficient and Opn-neutralized mice developed significantly milder disease. In addition, we constructed transgenic (Tg) mice overexpressing Opn only in DCs. These mice developed exaggerated colitis, and adoptive transfer of their CD103 − DCs into recipient mice dramatically exacerbated disease. Because Opn protein contains several domains interacting with various receptors, we defined a specific Opn domain significant for inducing proinflammatory properties in CD103 − DCs. Blockade of the interaction of this Opn domain [containing functional Ser-Leu-Ala-Tyr-Gly-Leu-Arg (SLAYGLR) sequence] with integrin α9 expressed on CD103 − DCs abrogated their proinflammatory profile and colitogenic effects in vivo.
Significance
Dendritic cells (DCs) are important for the development of intestinal inflammation in humans with inflammatory bowel disease (IBD) and in mice with experimental colitis. We demonstrate that a subset of DCs, CD103
− DCs, isolated from murine mesenteric lymph nodes, is highly pathogenic for murine intestinal inflammation and expresses high levels of the cytokine osteopontin (Opn). This Opn expression by CD103 − DCs is crucial for their pathogenicity. We define a specific domain of Opn protein significant for inducing pathogenic properties in CD103 − DCs. Blockade of the interaction of this Opn domain with integrin α9 expressed on CD103 − DCs abrogated their harmful effects. These findings may open new paths in IBD treatment.
Results

MLN CD103
− DCs Isolated from Mice with Colitis Are Proinflammatory in Vivo and in Vitro. MLNs are the main inductive site for IBD (3) . During acute colitis, there was a significant increase in the numbers of 7-aminoactinomycin D − (7AAD
− DCs (CD103 − DC subset) in colitic BALB/c mice in comparison to healthy controls ( Fig. 1A ; sequential gating strategy in Fig. 1B and Table S1 ). Most of these CD103
− DCs (∼80% in colitis vs. 70% in healthy MLNs) expressed the CD11b + marker (Fig. 1B and Table S1 ), denoting monocyte origin (38, 39) . CD11b −
CD103
− DC numbers were not altered significantly between these two groups (Table S1 ). Approximately 20% of colitic vs. 8% of healthy CD11b + CD103
− DCs expressed E-cadherin (Fig. 1B and Table S1 ), which characterizes a subset of monocytederived DCs (12) . On the other hand, the lymphocyte antigen 6C + (Ly6C
− DC population was decreased during colitis (Table S1 ). Overall, acute colitis mainly enhanced total numbers of monocyte-derived CD103
− DCs in MLNs. Accumulation of CD103
− DCs in MLNs increased in accordance with disease severity and in a TNBS dose-increasing manner (Fig. 1A) .
In contrast, 7AAD − CD3
− MHCII high CD11c high CD103 + DCs (CD103 + DC subset) numbers in MLNs of colitic mice were negatively correlated to increasing TNBS doses administered and the resulting degree of inflammation, and were significantly reduced overall (Fig. 1A) . Healthy mice had higher numbers of CD103 + DCs vs. CD103 − DCs in MLNs (Fig. 1A and Table S1 ). Accordingly, colitic mice had a significantly higher ratio of MLN CD103 − DCs to CD103 + DCs (DC ratio hereafter) in comparison to healthy mice, as well as mice with mild colitis (Fig. 1A) . CD103 − DCs from colitic mice exhibited higher Il23p19 and Il6 expression and higher IL-12p70 production compared with CD103
− DCs isolated from healthy control mice, whereas there was no significant difference in Il10 expression (Fig. 1C) . CD103
− DCs from colitic mice also expressed significantly higher levels of Spp1 (Fig. 1C) . The cytokine expression profile of MLN CD103
− DCs suggested that they have proinflammatory potential. To address this, we adoptively transferred (i.p.) MLN CD103
− DCs from colitic donors into healthy recipients 2 h before colitis induction. We analyzed recipient mice 5 d following colitis induction. As expected, the disease score was significantly higher in recipients of CD103
− DCs compared with nontransferred mice (Fig. 2A) . However, transfer of CD103 + DCs did not affect disease ( Fig. 2A) (Fig. S1A ).
Opn Expression Exacerbates Acute Colitis with Increased CD103
− DC Recruitment. Opn expression is up-regulated in peripheral blood and intestinal mucosa of patients (24) (25) (26) (27) (28) (29) and mice with IBD (14, 15, 27, 30) . We found that Opn protein and mRNA (Spp1) levels were also significantly higher in MLN cells (MLNCs) from mice with acute colitis (∼fourfold and ∼46-fold, respectively) compared with healthy mice (Fig. 2 D and E) . Specifically, MLN CD103 − DCs from colitic mice expressed significantly higher Spp1 levels than CD103 + DCs (Fig. 2F ). Induction of colitis in Opn-deficient (Spp1 −/− ) mice resulted in attenuated disease with significantly reduced inflammatory cell infiltration in the colonic mucosa, submucosa, and muscularis propria (Fig. 3A) . In comparison, WT mice had significantly enhanced inflammation, shortening of the colon, infiltration of inflammatory cells, and a high histological score (Fig. 3A) . Epithelial hyperplasia, the cardinal feature of TNBS-induced colitis (40) , was significantly decreased in the crypts of Spp1 −/− mice, reminiscent of the crypts of noninflamed colonic tissue (Fig. 3A) . Furthermore, Spp1 −/− mice had lower mortality rates at the peak of disease (∼8.3%) compared with WT mice (∼20%).
MLN homogenates from Spp1 −/− mice contained decreased levels of IL-23 and IL-12p70 and increased IL-10 levels in comparison to homogenates from WT mice (Fig. 3B) . Proliferation of CD4 + T cells isolated from MLNs from Spp1 −/− colitic mice was significantly reduced (Fig. S1B) . Also, their cytokine profile was characterized by significantly lower levels of IFN-γ and IL-17A, in comparison to CD4 + T cells from WT mice, whereas IL-10 secretion was significantly higher (Fig. S1C ). Phenotypic analysis of CD4 + T-cell populations revealed that MLNs from colitic Spp1 −/− mice had significantly reduced numbers of Th17 and Th1 cells (Fig.  3C ). MLNs of colitic Spp1 −/− mice contained significantly higher numbers of Foxp3 + and IL-10 + CD4 + T cells ( Fig. 3C ) with increased Foxp3 and Il10 expression (Fig. S1D) . Spp1 −/− mice also contained increased numbers of IL-10 + IL-17A + CD4 + T cells, characterized as regulatory cells in another colitis model (41) , in their MLNs (Fig. S1E) . mice per group) from three separate experiments. Statistical significance was obtained by an unpaired Student t test (**P < 0.01; ***P < 0.0002).
Opn deficiency during acute colitis resulted in higher MLN numbers of 7AAD − CD3 − MHCII high CD11c high DCs in comparison to WT mice (Fig. 3D) . Despite the overall increase in DC numbers, MLNs of Spp1 −/− mice had significantly reduced numbers of the CD103 − DC subset compared with WT mice (Fig. 3D ). In addition, there were significantly higher numbers of CD11b + CD103 − DCs and CD11b − CD103 − DCs in Spp1
vs. Spp1 −/− colitic mice (Fig. 3D ). The decrease of CD103 − DCs in the Spp1 −/− mice mainly reflected reduced numbers of the E-cadherin + CD11b + DC population (Fig. 3D ). Decreased numbers of Ly6C-expressing CD11b + CD11c high CD103 − DCs were also present in MLNs of Spp1 − /− vs. Spp1 +/+ colitic mice (Fig. 3D ). In addition, CD103
− DCs from Spp1 − /− mice expressed significantly lower levels of C-C chemokine receptor type 7 (CCR7) (Fig. S1G) , an important molecule for DC migration and homing to lymph node (LN) (42, 43) . In vivo BrdU incorporation by CD103 − DCs was similar between the two groups ( Fig. S1F) , suggesting that CD103 − DC numbers were dampened in Spp1 −/− mice as a result of decreased recruitment to MLNs, and not due to defective proliferation. There was no difference in proliferation of CD103 + DCs between Spp1 +/+ and Spp1 −/− colitic mice (Fig. S1F) . Nevertheless, colitic Spp1 −/− mice exhibited significantly increased numbers of CD103 + DCs (Fig. 3D ) with higher CCR7 expression (Fig. S1G) . Thus, the DC ratio was significantly lower in the MLNs of Spp1 −/− colitic mice compared with WT mice (Fig. S1H ). There were no differences in the numbers of MLN CD103
− and CD103 + DCs between healthy Spp1 −/− and WT mice (Fig. S1I ). Opn deficiency during colitis influenced lamina propria (LP) DC subset numbers as well. LP CD103 − DC numbers were decreased in Spp1 −/− mice similar to the MLNs. There was a significant decrease of CD103 + DC numbers in LP of Spp1 −/− mice, which was in contrast to their representation in MLNs. In addition, there was no difference in numbers of total LP E-cadherin +
CD103
− DCs between Spp1 +/+ and Spp1 −/− mice (Fig. S1J ). We found significantly decreased Il6, Il23p19, and Il27p28 expression; IL-12p70 secretion; and increased IL-10 secretion ( DCs. Also, Itga9 gene expression in DCs, encoding a known Opn receptor that favors IL-6 production in a rheumatoid arthritis (RA) model (19) , was significantly lower in Spp1 −/− CD103 − DCs (Fig. 4A) .
We also examined the acute colitis susceptibility of Spp1 −/− mice bred onto the Rag2 −/− background, which lack both T and B lymphocytes. BALB/c Rag2 −/− Spp1 −/− mice were significantly protected from colitis, because they exhibited a lower histological disease score (Fig. S1K) 
Spp1
−/− mice (Fig. S1M) . We also induced an additional acute colitis model, DSS colitis, in C57BL/6 Spp1 +/+ and Spp1 −/− mice. The effects of Opn were also proinflammatory in this model, because disease severity (Fig. S2A) , as well as Th17 and Th1 cell numbers, was significantly enhanced in Spp1 +/+ mice (Fig. S2B) 
recipients reconstituted with naive WT CD4 + T cells, followed by colitis induction. As expected, recipient mice transferred with WT CD103 − DCs had significantly higher disease scores than mice transferred with Spp1 −/− CD103 − DCs (Fig. S3C) . Accordingly, numbers of Th17 and Th1 cells were significantly elevated in MLNs of WT CD103 − DC recipients (Fig. S3D) . Overall, Opn expression by CD103
− DCs contributes significantly to their proinflammatory capacity in vivo.
Given the pathogenic potential of MLN CD103 − DCs, we studied whether Opn production exclusively by these cells is efficient to exacerbate colitis in BALB/c Spp1 −/− mice that are otherwise protected. For this, we transferred WT CD103 − DCs obtained from MLNs of colitic mice into Spp1 −/− recipients before mild colitis induction. Spp1 −/− recipients of colitic WT CD103 − DCs had a significantly enhanced colitis score (Fig. 4C) . − and CD103 + DCs. Values are from one representative experiment (*P < 0.05; **P < 0.01; ***P < 0.0005).
enhanced colitis upon DSS administration (Fig. S2E). Transfer of Spp1
−/− CD103 − DCs did not exacerbate colitis in C57BL/6 Spp1 −/− recipients (Fig. S2E ).
MLN CD103
− DCs exhibit high expression of TLR-4 (7, 12), whereas bacterial LPS is present in the intestinal lumen (44) .
Steady-state WT CD103
− DCs stimulated with LPS had significantly higher expression of Il6, Il23p19, Il27p28, and Itga9, as well as a modest elevation in IL-12p70 secretion, compared with Spp1
− DCs isolated from colitic mice are preconditioned in an inflammatory environment, and this may alter their original function in addition to their Opn expression. Adoptive transfer of LPSpretreated WT CD103
− DCs from healthy mice into BALB/c Spp1 −/− mice before colitis induction resulted in a significantly enhanced disease score compared with Spp1 −/− CD103 − DC recipients (Fig. 4E) . Accordingly, the higher histological score was accompanied by significantly elevated total numbers of CD103
−
DCs in MLNs of WT CD103
− DC recipients (Fig. 4F) . Also, WT CD103 − DC recipients had significantly decreased total numbers of MLN CD103 + DCs. Overall, these results demonstrate that steady-state Opn-expressing MLN CD103
− DCs are predisposed to proinflammatory function. In addition, Opn derived exclusively from CD103
− DCs worsens disease significantly.
Opn-Overexpressing CD103
− DCs Are Highly Pathogenic. We have generated conditional C57BL/6 Tg mice that contain the Spp1 allele downstream of a stop cassette flanked by loxP sites (Spp1-stop f/f ) ( Fig. 5A ). C57BL/6 Spp1-stop f/f mice overexpress the Spp1 allele when crossed to a mouse strain expressing Cre recombinase due to deletion of the stop cassette (Fig. 5A) − DCs in MLNs of tamoxifen-treated double-Tg colitic mice compared with nontreated colitic littermates (Fig. S4C) . We also isolated naive MLN CD103 − DCs from treated or nontreated double-Tg Spp1-stop f/f / CreER T1 mice and transferred them into WT recipients. We induced colitis in recipient mice and observed that Spp1 overexpression exclusively by CD103
− DCs was sufficient to exacerbate disease severity (Fig. 5D ), accompanied by increased numbers of Th17 and Th1 cells, whereas it restrained Foxp3 + Tregs and IL-10 + CD4 + T cells in MLNs (Fig. 5E ). The DC ratio was also significantly increased in recipients of Opn-overexpressing CD103 − DCs (Fig. 5F ), accompanied by elevated Spp1, Il17a, Il6, and ll23p19 expression and reduced Il10 and Foxp3 expression in MLNs compared with recipients of control CD103
− DCs (Fig.  S4D) . A similar trend was noted for IL-17A, IL-6, IFN-γ, and IL-10 secretion by MLNCs (Fig. S4E) . Conclusively, transfer of naive MLN CD103
− DCs, which overexpress Opn, significantly boosts disease severity in WT recipient mice.
We also generated mice with DC-specific Opn overexpression by crossing the C57BL/6 Spp1-stop f/f mice to Itgax cre mice. The double DC-Tg C57BL/6 (Spp1-stop f/f /Itgax cre ) mice overexpressed Opn only in DCs ( In the above experimental approach, all DC subsets overexpress Opn. We thus transferred naive Opn-overexpressing MLN CD103
− DCs from Spp1-stop f/f /Itgax cre mice or control naive MLN CD103 − DCs from Spp1
recipients. Induction of colitis in recipient mice resulted in significant disease exacerbation ( Fig. 6C ) and enhancement of Th17 and Th1 cellularity (Fig. S5D ). Numbers of Foxp3 + Tregs were also decreased, whereas there was no significant difference in IL-10 + CD4 + T cells (Fig. S5D) . Consistently, MLNCs derived from mice transferred with Opn-overexpressing CD103 − DCs secreted higher levels of IFN-γ, Opn, IL-17A, and IL-6 compared with mice transferred with control CD103 − DCs, whereas there was no significant difference in IL-10 levels (Fig.  S5E) Values are expressed as mean ± SEM (n = 4 mice per group) from two separate experiments (*P < 0.05; **P < 0.005; ***P < 0.001).
overexpressed just in CD103
− DCs was sufficient to exacerbate chronic colitis significantly in Spp1 −/− recipient mice.
Opn Secreted by CD103
− DCs Mediates Colitis Exacerbation. DCs express both the secreted Opn (Opn-s) (18, 19, 21, 35) and intracellular Opn (Opn-i) (17, 33, 34) − DC recipients treated with Ig-isotype compared with recipients treated with anti-Opn, which had similar scores as Spp1 −/− CD103 − DC recipients (Fig. 7A ). This result was accompanied by significantly elevated DC ratios in MLNs (Fig.  7B ). Th17 and Th1 responses were significantly increased in Igtreated compared with anti-Opn-treated recipients of WT CD103 − DCs and also compared with Spp1 −/− CD103 − DC recipients (Fig. 7C) . As expected, MLNs from Ig-treated recipients produced significantly more IL-17A, IL-6, and IFN-γ ex vivo (Fig. S6A ) and expressed higher levels of Il17a, Il6, Il23p19, and Itga9 compared with the two other groups (Fig. S6B) − DC recipients (Fig. 7D) . Colitis protection conferred from neutralization of CD103 − DC-derived Opn-s demonstrates the importance of this Opn isoform in this setting.
Neutralization of Opn-s as a Colitis Treatment. We also addressed the effects of systemic Opn neutralization in WT mice. Mice treated with anti-Opn were less susceptible to acute colitis, with significant differences in colon length (Fig. S7A ) and histological inflammation scores (Fig. S7B ) compared with Ig-treated controls. In addition, anti-Opn-treated mice exhibited significantly reduced numbers of macrophages, neutrophils, and lymphomononuclear cells ( + T-cell cultures from Ig-treated controls (Fig. S7E) . Importantly, anti-Opn administration resulted in significantly impaired recruitment of CD103 − DCs to MLNs; increased numbers of CD103 + DCs; and, consequently, decreased DC ratio (Fig. S7F) . Effector Th17 and Th1 cell numbers were significantly decreased by anti-Opn administration, whereas the Foxp3 + Treg numbers were substantially elevated in MLNs (Fig.  S7G ). Our results demonstrate that in vivo neutralization of Opn-s ameliorates disease, suggesting a possible therapeutic approach. + cells (per 10 6 MLNCs) (E) and DC ratios (F) are shown. Values are expressed as mean ± SEM (n = 6 mice per group) from three separate experiments (**P < 0.01; ***P < 0.001).
SLAYGLR Motif of Opn-s Is Responsible for Its CD103
− DC-Mediated Proinflammatory Action. Opn-s has certain domains that interact with integrins expressed in DCs (45) . We tested the effects of two synthetic Opn-s fragments (Opn 134-153 ), RGD (Arg-Gly-Asp)-SLAYGLR (frOpn RGD ) and RAA (Arg-Ala-Ala)-SLAYGLR (frOpn RAA ), during colitis (Fig. S6C) . The frOpn RGD includes the RGD domain that interacts with αvβ1, αvβ3, αvβ5, αvβ6, α5β1, and α8β1 (46-48), as well as the SLAYGLR motif that interacts with integrins α9β1, α4β1, and α4β7 (49-51) (Fig. S6C) . The frOpn RAA contains the inactive RAA domain in the place of the RGD and the intact SLAYGLR motif (Fig. S6C) (Fig. 8A) , a higher DC ratio (Fig. 8B) , and elevated numbers of Th17 and Th1 cells in MLNs (Fig. 8C) (Fig. 4A) and Itga9 expressed on conventional DCs (cDCs) has a role in Th17 induction in an RA model (19 (Fig. 9B) . Accordingly, there was significantly decreased IL-17A, IL-6, and IFN-γ production by MLNCs from recipients transferred with anti-α9/ frOpn RAA -treated CD103 − DCs compared with Ig/frOpn RAAtreated CD103
− DC recipients (Fig. 9C) . Also, transfer of anti-α9/ frOpn RAA -treated Spp1 −/− CD103 − DCs increased IL-10 levels in MLNCs compared with transfer of Ig/frOpn RAA -treated CD103 − DCs (Fig. 9C) . Interestingly, frOpn RGD (Fig. S6D) .
Discussion
Intestinal CD103
− DCs have been generally characterized as proinflammatory for colitis (12) . In this report, we demonstrate that MLN CD103
− DCs are indeed pathogenic and express, among other proinflammatory cytokines, high levels of Opn. Although there is up-regulated Opn expression in plasma and intestinal tissue from patients and mice with IBD (14, 15, 24-30, 52), its specific role had not been determined. We found that Opn expression by CD103 − DCs is crucial for their pathogenicity. Overall, our results elucidate a previously unappreciated role for Opn in colitis and its relation to CD103
− DC-mediated responses. The pathogenicity of CD103 − DCs has been studied using only bone marrow-derived CD103 − DCs resulting from in vitro treatment with GM-CSF (11, 12) . Here, we show that CD103 − DCs directly isolated from MLNs express IL-6, IL-12, IL-23, and Opn and are pathogenic for colitis. Acute colitis caused an elevation in MLN CD103
− DC numbers, and this significant rise was mainly due to the development of CD11b + DCs. Expression of CD11b by CD103 − DCs denotes their origin from blood monocytes, and these monocyte-derived DCs (moDCs) present in MLNs have proinflammatory properties upon colitis (9, 12, 39, 53) . Consequently, adoptive transfer of total MLN CD103 − DCs (containing both the CD11b − and the CD11b + subpopulations) into recipients predisposes them to severe colitis, and this potential is linked to their levels of Opn expression. Adoptive transfers of CD103 − DCs in Opn-deficient Rag1 −/− mice with chronic CD4 + T-cell transfer colitis resulted in disease augmentation, and inflammation was further elevated when transferred 
/CreER T1 mice). Opn expression in CD103
− DCs isolated from healthy mice is essential for their colitogenic activity, which is also revealed upon adoptive transfer of these cells. Thus, recipients of Opn-deficient CD103 − DCs showed dramatic attenuation of disease compared with recipients of WT CD103 − DCs. Recent studies demonstrate that Opn derived from a broad DC subset, known as cDC subset, induces Th17 cells (17, 18) and has been linked to increased IL-6 production by cDCs (19) . Past studies described the role of Opn in whole cDCs, whereas we addressed here the effects of Opn produced by CD103 − DCs, a subpopulation of cDCs important for colitis (12) . Our results showed Opn-mediated Th17 induction which was readily explained by the dramatic increase in IL-23 and IL-6 expression by Opn-expressing CD103 − DCs. Interestingly, although Th1 responses were significantly enhanced, we found only modest elevations in IL-12 secretion by Opn-expressing CD103 − DCs. It is possible that IL-23 and IL-6, apart from Th17 response induction, may also reinforce Th1 responses (54, 55) . We also observed that CD103 − DC-derived Opn enhances their IL-27 expression upon colitis. This is in contrast to a study describing that cDC-derived Opn induces Th17 responses mainly through the inhibition of IL-27 in the experimental autoimmune encephalomyelitis (EAE) model (17) . However, a recent report demonstrates that IL-27 is detrimental for colitis because it mediates survival of activated CD4 + T cells, resulting in enhanced disease severity (56) . In addition, IL-27 inhibits Foxp3 induction in CD4 + T cells in vitro (57) . Thus, certain differences in the observed Opn effects on IL-27 production between our study and previous studies (17) may be attributed to special features of gut-associated CD103 − DCs and require further investigation.
Colitis, in comparison to steady state, resulted in ∼20% elevation in the numbers of E-cadherin + CD103 − CD11b + MLN DCs, a subset similar to the previously described highly proinflammatory moDC subset (12 (4) (5) (6) (7) (8) (9) . A previous study demonstrated that Opn-deficient C57BL/6 mice had decreased severity of very early acute TNBS colitis (3 d) (14) . However, studies addressing the role of Opn during DSS-induced colitis, another chemically induced model, have been contradictory (14, 15, (60) (61) (62) (63) . Opn deficiency in Black Swiss mice was protective (15) , whereas Opn deficiency in C57BL/6 mice resulted in increased intestinal tissue destruction (60) and exacerbated disease phenotype (61) . Our results demonstrate that Opn is proinflammatory in both the TNBS model and the DSS model, because WT mice have significantly increased severity and pathogenic Th17 and Th1 cell numbers in comparison to Opn-deficient mice. Contradictory results on the DSSinduced colitis can be attributed to differences in the methods used. For example, Da Silva et al. (60) administered a significantly higher dose of DSS in mice (5% DSS, double the dose used in standard protocols and in our protocol). Heilmann et al. (61) found that Opn was anti-inflammatory during acute DSS colitis but proinflammatory during chronic DSS colitis. We have not tested chronic DSS colitis; however, our studies on T-cell transfer chronic colitis showed that Opn expression by CD103 − DCs exacerbated disease.
Here, we also demonstrate that TNBS and DSS colitis can develop in Rag −/− mice. TNBS-driven colitis is initiated by intrarectal instillation of a solution of ethanol, which breaks the mucosal barrier, with TNBS, which haptenizes autologous colonic or microflora proteins, leading to Th1 and Th17 responses (64) . Despite the fact that the TNBS colitis model was traditionally considered T cell-dependent (65), studies have demonstrated that it can develop in the absence of adaptive immunity (66) . Chemical haptens are sensitizers with a high ability to elicit DC migration from the sites of sensitization to draining LNs to present antigens and activate immune responses (67) . Thus, initiation of the TNBS-induced colitis relies a lot on DCs and other innate cells (67) . A previous study demonstrates that TNBS-driven colitis can develop in Rag −/− mice and can be suppressed with anti-α1-integrin treatment, which prevents mononuclear LP cells from proliferating and producing IFN-γ (66). In addition, DSS, another chemical that destroys the integrity of the mucosa, can cause colitis in the absence of adaptive immunity (68) . In our experiments, Rag −/− Spp1 +/+ mice are more susceptible to TNBS or DSS colitis compared with Rag DC Opn is expressed in two isoforms: Opn-s and Opn-i (34), generated by alternative translation of the Spp1 mRNA (17, 33) .
Neutralization of the CD103
− DC-derived Opn in colitic Opndeficient mice transferred with WT CD103 − DCs resulted in ameliorated disease and revealed that it was the Opn-s isoform mainly responsible for the proinflammatory phenotype of the CD103 − DCs. Opn-s, from CD103 − DCs or other cellular sources, probably acts on CD103 − DCs to potentiate their colitogenic function. Indeed, pretreatment of Opn-deficient CD103 − DCs with rOpn or certain Opn fragments resulted in their enhanced pathogenicity upon transfer into recipients. Although we find that Opn-s drives the colitogenic activity of CD103 − DCs, we do not exclude possible contributions by Opn-i in these cells during colitis. Elegant studies show that Opn-i expression by DCs promotes inflammation in antiviral (34) and autoimmune responses (17) . Specifically, Opn-i mediates TLR-9-induced expression of IFN-α in plasmacytoid DCs (pDCs) via interactions with MyD88 (34), and Opn-i inhibition in IFN-α-activated cDCs dampens Th17 cell commitment through IL-27 production in EAE (17) . Because MLN CD103
− DCs express high levels of TLR-2, TLR-4, and TLR-9 (7, 12), they could possibly be subjected to Opn-i-mediated TLR regulation during intestinal inflammation. Specifically, because TLR-9 engagement and subsequent type I IFN production are protective in acute colitis (75) , Opn-i from CD103 − DCs and/ or from other DC subsets, such as pDCs, could influence disease.
Through its RGD (46) (47) (48) and SLAYGLR domains (49, 50) , Opn interacts with integrins expressed on several cell types, such as fibroblasts, endothelial cells, and epithelial cells, as well as on a variety of immune cells (45, 76) . The SLAYGLR Opn domain contributes to RA development (77, 78) and interacts with integrins α9 and α4 (49) (50) (51) . Upon inflammatory conditions, thrombin cleaves Opn-s right downstream of the SLAYGLR sequence, exposing an extra integrin-binding site (79) . Integrin α4 can interact with SLAYGLR in full-length Opn, whereas integrin α9 interacts only with the thrombin-exposed SLAYGLR motif (79) (80) (81) . Here, we demonstrate that the proinflammatory effect of Opn on CD103
− DCs was mainly mediated by the Opn SLAYGLR domain, because DC pretreatment with a synthetic Opn fragment (frOpn RAA ) containing exposed SLAYGLR and mutated RGD domain enhanced their pathogenicity. Blockade of integrin α9 during Opn SLAYGLR pretreatment of Opndeficient CD103
− DCs resulted in suppression of their proinflammatory profile and dramatically decreased their pathogenicity upon transfer into recipient mice. This indicated that integrin α9 mediates the observed Opn effects on CD103 − DCs. In collageninduced arthritis, blockade of the interaction of tenascin-C (TN-C) with integrin α9, expressed on cDCs, down-regulated their IL-6 expression (19) . Our results demonstrated that colitis induction or LPS stimulation caused significant up-regulation of both Opn and Itga9 expression in WT CD103 − DCs. Interestingly, frOpn treatment of LPS-stimulated CD103 − DCs enhanced their Itga9 expression. Thus, it appears that inflammatory stimuli propagate circles of interactions of Opn and integrin α9. It has to be emphasized that there are other candidate ligands of integrin α9, such as TN-C, vascular cell adhesion molecule-1, and VEGF-A (19, (82) (83) (84) , some of which are overexpressed in the colitic microenvironment (85, 86) . It is unknown whether interactions of these molecules with integrin α9 on CD103 − DCs enhance or restrain the described proinflammatory function of Opn.
As mentioned, CD103 − DCs are a source of Opn, which can act on them in an autocrine manner. However, Opn secreted by other cells, such as epithelial and LP mononuclear cells in the colitic microenvironment (25, 26, 63) , could affect CD103 − DCs in a paracrine manner. Here, we show that Opn expressed by CD103 − DCs is crucial for the colitogenic effect of these cells. One of the mechanisms mediating this potentiation could be autocrine or paracrine Opn-s (and especially its SLAYGLR domain) acting on CD103 − DCs, enhancing their IL-23 expression. Nevertheless, receptors for Opn (several integrins and CD44 isoforms) are expressed on cell types like fibroblasts, endothelial cells, and epithelial cells, as well as on a variety of immune cells like T cells and macrophages (45, 76) . This implies that cells other than DCs are subjected to changes through Opn signals in the inflammatory environment of colitis, which is Opn-rich (25) .
We have demonstrated that Opn expression during allergen sensitization differentially influences recruitment of DC subsets by enhancing recruitment of proinflammatory cDCs while restraining recruitment of tolerogenic pDCs (35) . In addition, Opn-deficient mice have a defect in trinitrochlorobenzeneinduced DC migration in draining LNs (37), whereas Opn treatment may dampen DC migration during bacterial infection (87) . In the current study, WT colitic mice and Opn-deficient colitic recipients of transferred WT CD103 − DCs exhibited higher total MLN CD103 − DC numbers in comparison to Opn-deficient mice and recipients of Opn-deficient CD103
− DCs, respectively.
Increases in CD103
− DC numbers were accompanied by concomitant reductions in CD103 + DC numbers, and thus a higher MLN DC ratio (CD103 − /CD103 + DCs), reflecting exacerbated disease. We showed that this Opn effect on MLN DC ratio was not due to enhanced proliferation of CD103 − DCs and/or reduced proliferation of CD103 + DCs but to differential influence on the CD103 + and CD103 − DC accumulation in MLNs. However, whether this is a direct effect of Opn on DC subset recruitment is unknown. Opn itself can act as a chemotaxis molecule for DCs (20, 37, 88) . Whether CD103 − DCs preferentially bear certain Opn receptors that eventually influence their MLN recruitment remains unknown. Our study suggests that the DC subset ratio, the numbers of CD103
− DCs, and their Opn and possibly surface integrin α9 expression can be useful disease biomarkers.
Opn is up-regulated in IBD (24) (25) (26) (27) (28) (29) and several other inflammatory conditions (16-21, 89) . However, whether this upregulation can be attributed to specific cellular sources remains elusive. It is possible that patients with CD have enhanced Opn or integrin α9 expression in CD103 − DCs, predisposing them to disease. The Spp1-stop f/f
/Itgax
cre Tg mice we constructed were overexpressing Opn only in their DCs, and this rendered them susceptible to severe colitis. Targeting of cytokines is extensively used in the therapy of immune disorders, including IBD (90) . In addition to cytokines, several integrins like integrin α1β1 and integrin α4β7 are known to be essential for colitis pathology (66) and have been proposed as potential target molecules for therapy (66, 91, 92) . However, their systemic blockade can cause generalized immunosuppression (92) , similar to the broadly used anti-TNF-α (90). Thus, a more focused anti-inflammatory therapy for colitis is necessary. We showed that disrupting the interaction of the Opn SLAYGLR domain with integrin α9 overexpressed on the colitic CD103 − DCs suppressed the proinflammatory function of these cells, opening scientific questions and suggesting future therapeutic approaches for IBD.
Materials and Methods
Colitis studies were performed in 8-to 10-wk-old male mice. For acute colitis induction, mice were administered 1-3 mg of TNBS (Sigma-Aldrich) in ethanol intrarectally as previously described (64 f/f mice, we assessed transgene construction cloning of the full-length mouse Spp1 (mSpp1) cDNA; the sense primer 5′-CTAACTACGACCATGAGATTGG-3′ and the antisense primer 5′-GGGTATAGTGATATAGACTG-3′ were used, and a 1,269-bp product was obtained. The cDNA product encoding osteopontin (Opn; NM_009263) was cloned as an EcoRI (New England BioLabs) fragment into the plasmid chicken actin LoxP stop LoxP (pCALSL) expression vector (a gift from R. Kelleher, Massachusetts General Hospital, Boston). The construct was created by subcloning the pCALSL vector and inserting a general eukaryotic promoter of chicken b-actin that drives the expression of a downstream intron inserted as a transcriptional enhancer. Downstream of the intron, there was inserted a stop cassette flanked by loxP sites. The mSpp1 cDNA was cloned downstream of the last loxP site. The loxP-flanked stop sequence contains a neocassette and a triple-polyadenylation (tpA) sequence at the 3′ end of the neoexpression cassette. Transcriptional read-through is prevented with the use of a tpA (stop) sequence. The correct 5′-3′ orientation of the mSpp1 cDNA was confirmed with HincII and NotI (New England BioLabs) digestion of the construct. An SV40 late polyadenylation signal (0.4 kbp) was added downstream of the mSpp1 cDNA, and to verify the insertion, the product was digested with XbaI and SalI (New England BioLabs). The construct was isolated with an Endofree Kit (Qiagen), and SalI digestion followed to delete the prokaryotic backbone elements of the transgene construct. The final sequence (6.6-kbp fragment) was obtained with a Geneclean Gel Extraction Kit (Qiagen). The clean sequence containing the transgene construction was microinjected into mouse eggs (B6) to a final concentration of 50-100 ng/μL. The surviving eggs were transplanted into oviducts of foster mothers. The loxPflanked DNA stop sequence prevents expression of the downstream Spp1 gene. When Tg mice are crossed with a Cre-expressing strain, the stop sequence is removed in their litters and Opn is expressed in cells/tissues where Cre is expressed. All double-Tg mice, Spp1-stop f/f /CreER T1 and Spp1-stop f/f /Itgax cre , were healthy and bred well. Opn overexpression in the doubleTg Spp1-stop f/f /CreER T1 mouse was induced after daily i.p. administration of 1-3 mg of tamoxifen (Sigma) diluted in 200 μL of corn oil (Sigma) per mouse.
In Vivo Experimental Protocols. Colitis studies were performed in specific pathogen-free 8-to 10-wk-old male mice. For acute colitis Histology. Colons were excised for macroscopic damage evaluation and length measuring. Colon tissue was cut vertically or longitudinally, fixed in 10% (vol/vol) buffered formalin, and embedded in paraffin. Tissue sections that depict midcolon areas (5 μm) were stained with H&E, periodic acid-Schiff, and Giemsa. In H&E staining photomicrographs, the original magnification is 20×, with a 100-μm scale bar, unless otherwise stated. The degree of inflammation and the differential cell numbers on microscopic sections were graded blindly. The scoring systems used for acute TNBS colitis (2), acute DSS colitis (3), and chronic CD4 + T-cell transfer colitis (4) were described previously.
Cell Isolation and Culture, Cytokine Analysis, and Proliferation Assays. We used a previously described method to isolate cells from draining lymph nodes (5) or colonic lamina propria (LP) (6) . Mesenteric lymph node cells (MLNCs) from healthy or colitic mice were harvested, pooled from each mice group, stimulated ex vivo with 1 μg/μL LPS (Sigma) or 2 μg/mL soluble anti-CD3 (12A.2; BD Biosciences) and 3 μg/mL anti-CD28 (37.71; BD Biosciences). Cells were isolated with the CD4 + T-Cell Isolation Kit II and stimulated with 2 μg/mL anti-CD3. MLN dendritic cells (DCs) were isolated with a CD11c Microbead Kit (Miltenyi Biotec); the CD103 − DC fragment was obtained with negative selection and the CD103 + DCs were obtained with positive selection from the whole DCs with a CD103 (integrin αE) mouse affinity-purified Ab (BD Pharmingen) and sheep anti-rat Dynabeads (Invitrogen). Alternatively, after DC enrichment with the CD11c Microbead Kit, the following anti-mouse Abs were used for purification of CD11c Opn (***P = 0.0003; ***P = 0.0001), IFN-γ (***P = 0.0002; ***P = 0.0001), IL-17A (**P = 0.0017; ***P < 0.0001), IL-6 (**P = 0.002; ***P < 0.0001), and IL-10 secretion by LPS-and anti-CD3/28-stimulated (72 h) MLNCs (A) and percentages of activated effector CD44 high CD62L + CD4 + T cells (B) and CD103 − or CD103 + DCs (C) in MLNs of C57BL/6 Spp1-stop f/f CreER T1 colitic mice (−T/+T). Relative Spp1, Il17a, Il6, Il23p19 (***P < 0.0001), Il10 (***P = 0.0004), and Foxp3 (***P < 0.0001) mRNA expression (D) and levels of IL-17A (**P = 0.0013), IL-6 (***P = 0.0006), IFN-γ (***P = 0.0007), and IL-10 (***P = 0.0003) by 10 6 anti-CD3/28-stimulated (72 h) MLNCs (E) from colitic C57BL/6 recipients of Spp1-stop f/f CreER T1 CD103 − DCs (−T/+T). Values are expressed as mean ± SEM (n = 6 mice per group) from three separate experiments. Statistical significance was obtained by an unpaired Student t test. Relative mRNA expression of Il17a (**P = 0.0014; **P = 0.001; ***P = 0.0002), Il6 (**P = 0.003; ***P < 0.0001; ***P = 0.0003), Il23p19 (**P = 0.0011; ***P = 0.0003; ***P = 0.0001) and Itga9 (*P = 0.0147; ***P = 0.0005; ***P = 0.0002) in colitic MLNCs. Values are expressed as mean ± SEM (n = 5 mice per group) from three separate experiments. Fig. 1B ) (*P < 0.0354; **P < 0.0068; ***P < 0.0005). All values are expressed as mean ± SEM (n = 4 mice per group) from two separate experiments. Ly6C, lymphocyte antigen 6C.
